SCHEMBL7874583

SCHEMBL7874583

COCCNC(=O)Oc1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NCCCc3ccccc3)cc2)cn1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.45
RAB9A P51151 5/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
EPHX2 P34913 1/20 0.44
P4HTM Q9NXG6 2/20 0.43
GABRA5 P31644 2/20 0.43
HPGD P15428 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
NAMPT P43490 1/20 0.42
OPRK1 P41145 2/20 0.42
MLYCD O95822 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7867808 0.97 HSP90AA1 (0.44) NPC1RAB9ASMN1; SMN2EPHX2P4HTM
SCHEMBL7871550 0.92 NPC1 (0.43) NPC1RAB9ASMN1; SMN2EPHX2P4HTM
SCHEMBL7870523 0.92 MEN1 (0.47) NPC1RAB9ASMN1; SMN2P4HTMGABRA5
SCHEMBL7871636 0.92 RAB9A (0.46) NPC1RAB9ASMN1; SMN2EPHX2P4HTM
SCHEMBL7870451 0.91 NPC1 (0.46) NPC1RAB9ASMN1; SMN2EPHX2P4HTM
SCHEMBL7871663 0.91 EPHX2 (0.49) EPHX2P4HTMGABRA5NAMPTOPRK1
SCHEMBL7867912 0.91 EGFR (0.47) NPC1RAB9ASMN1; SMN2EPHX2P4HTM
SCHEMBL9574776 0.90 ALDH1A1 (0.44) NPC1RAB9ASMN1; SMN2P4HTMHPGD
SCHEMBL9018179 0.89 NPC1 (0.49) NPC1RAB9ASMN1; SMN2EPHX2P4HTM
SCHEMBL7869442 0.89 EGFR (0.43) P4HTMGABRA5HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed